All In Biotech

Drug Trial Radar · NCT04625907

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Last checked: Nov 19, 2026Latest source record: May 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 1,672 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,672

Planned (sponsor's estimate)

Start

Sep 17, 2020

Primary completion

Jun 2030

Study completion Jun 2030

Sponsor

Lead sponsor
University of BirminghamAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 12, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

FaR-RMS is an over-arching study for children and adults with newly diagnosed and relapsed rhabdomyosarcoma (RMS)

Conditions

  • Rhabdomyosarcoma

Interventions

  • IrinotecanDrug

    antineoplastic enzyme inhibitor

  • Actinomycin DDrug

    Antineoplastic agent that is a polypeptide antibiotic

  • DoxorubicinDrug

    An anthracycline topoisomerase inhibitor isolated from streptpmyces peucetius var. casesius

  • IfosfamideDrug

    chemotherapeutic agent chemically related to the nitrogen mustards and is a synthetic analog of cyclophosphamide

  • VincristineDrug

    anti neoplastic vinca alkaloid agent

  • VinorelbineDrug

    vinca alkaloid with a role as an antineoplastic agent

  • CyclophosphamideDrug

    Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent

  • TemozolomideDrug

    oral antineoplastic alkylating agent

  • radiotherapyRadiation

    Ionising radiation

  • RegorafenibDrug

    Oral multi-kinase inhibitor that targets a broad range of angiogenic, stromal and oncogenic kinases, including vascular endothelial growth factor receptors (VEFGR) 1, 2 and 3, tyrosine kinase with immunoglobulin and epidermal growth factor homology domain 2 (TIE2), platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptors (FGFR), c-KIT, RET, RAF-1 and BRAF (wild-type and V600E mutant).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event Free Survival (RT2)Time frame: From randomisation to first failure event, timeframe 36 months
  2. Event Free Survival (CT1A)Time frame: From randomisation to first failure event, timeframe 36 months
  3. Event Free Survival (CT1B)Time frame: From randomisation to first failure event, timeframe 36 months
  4. Event Free Survival (CT2A)Time frame: From randomisation to first failure event, timeframe 36 months
  5. Event Free Survival (CT2B)Time frame: Time from randomisation to first failure event, timeframe 36 months
  6. Event Free Survival (CT3)Time frame: Patients will be followed up for a minimum of 6 years from trial entry (or 5 years from end of relapsed trial treatment, whichever comes later). Patients will be followed up for progression and death until the end of trial definition has been met.
  7. Local Failure Free Survival (RT1A and RT1B)Time frame: Time from randomisation to first local failure event, timeframe 36 months
  8. Local Failure Free Survival (RT1C)Time frame: Time from randomisation to first local failure event, timeframe 36 months

Locations

128 sites in 20 countries. Site status is shown where the registry gives one.

  • Queensland Children's Hospital

    Brisbane, Australia · Recruiting

  • Chris O'brien Lifehouse

    Camperdown, Australia · Recruiting

  • Monash Children's Hospital

    Clayton, Australia · Recruiting

  • Peter Maccallum Cancer Centre

    Melbourne, Australia · Recruiting

  • Royal Childrens Hospital Melbourne

    Melbourne, Australia · Recruiting

  • John Hunter Children's Hospital

    New Lambton Heights, Australia · Recruiting

  • Perth Children's Hospital

    Perth, Australia · Recruiting

  • Sydney Children's Hospital

    Sydney, Australia · Recruiting

  • The Childrens Hospital At Westmead

    Sydney, Australia · Recruiting

  • Westmead Hospital

    Westmead, Australia · Recruiting

  • Princess Alexandra Hospital

    Woolloongabba, Australia · Recruiting

  • Kepler University Clinic Linz

    Linz, Austria · Recruiting

  • St Anna Childrens Hospital

    Vienna, Austria · Recruiting

  • Cliniques Universitaires Saint Luc

    Brussels, Belgium · Recruiting

  • Hopital Universitaire Des Enfants Reine Fabiola

    Brussels, Belgium · Recruiting

  • Universitair Ziekenhuis Gent

    Ghent, Belgium · Recruiting

  • Uz Leuven Campus Gasthuisberg

    Leuven, Belgium · Recruiting

  • Centre Hospitalier Regional De La Citadelle

    Liège, Belgium · Recruiting

  • Clinique Chc Montlegia

    Liège, Belgium · Recruiting

  • Masaryk University Hospital Brno

    Brno, Czechia · Recruiting

  • Aarhus University Hospital

    Aarhus, Denmark · Recruiting

  • University Hospital Rigshospitalet

    Copenhagen, Denmark · Recruiting

  • Centre Hospitalier Universitaire D'angers

    Angers, France · Recruiting

  • Centre Hospitalier Regional Universitaire Besancon - Hopital Jean Minjoz

    Besançon, France · Recruiting

  • Centre Hospitalier Universitaire De Bordeaux - Hopital Pellegrin

    Bordeaux, France · Recruiting

  • Centre Hospitalier Regional Universitaire Brest - Hopital Morvan

    Brest, France · Recruiting

  • Centre Francois Baclesse

    Caen, France · Recruiting

  • Centre Hospitalier Universitaire De Caen

    Caen, France · Recruiting

  • Centre Hospitalier Universitaire Dijon Bourgogne - Hopital D'enfants

    Dijon, France · Recruiting

  • Centre Hospitalier Universitaire De Grenoble

    Grenoble, France · Recruiting

  • Centre Hospitalier Universitaire La Reunion

    La Réunion, France · Recruiting

  • Centre Oscar Lambret

    Lille, France · Recruiting

  • Centre Leon Berard

    Lyon, France · Recruiting

  • Hopital De La Timone (ap-hm)

    Marseille, France · Recruiting

  • Centre Hospitalier Universitaire De Nancy

    Nancy, France · Recruiting

  • Centre Hospitalier Universitaire De Nantes

    Nantes, France · Recruiting

  • Hopital Armand Trousseau

    Paris, France · Recruiting

  • Institut Curie

    Paris, France · Recruiting

  • Centre Hospitalier Universitaire Haut Levque

    Pessac, France · Recruiting

  • Centre Hospitalier Universitaire De Poitiers

    Poitiers, France · Recruiting

Showing 40 of 128 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.